Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Viking Therapeutics, Inc. - Common Stock (NQ: VKTX )

30.48 +0.98 (+3.32%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,282,032
Open 29.60
Bid (Size) 30.48 (2)
Ask (Size) 30.50 (1)
Prev. Close 29.50
Today's Range 29.50 - 30.88
52wk Range 28.64 - 99.41
Shares Outstanding 99,581,693
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
This GE Vernova Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Via Benzinga
$100 Invested In Viking Therapeutics 5 Years Ago Would Be Worth This Much Today
Via Benzinga

Performance

YTD
-25.88%
-25.88%
1 Month
-6.39%
-6.39%
3 Month
-37.94%
-37.94%
6 Month
-54.25%
-54.25%
1 Year
-15.80%
-15.80%

More News

Read More
Why Hims & Hers Health Stock Crushed Novo Nordisk and Viking Therapeutics Today
Via The Motley Fool
2 Stocks to Buy With Less Than $40
Via The Motley Fool
3 No-Brainer Healthcare Stocks to Buy With $200 Right Now
Via The Motley Fool
2 Stocks That Could Soar Again in 2025
Via The Motley Fool
Has the Bubble Burst for Viking Therapeutics Stock?
Via The Motley Fool
Earnings Scheduled For February 5, 2025
Via Benzinga
(VKTX) - Analyzing Viking Therapeutics's Short Interest
Via Benzinga
This Biotech Stock Soared 116% in 2024, but Is It a Buy in 2025?
Via The Motley Fool
Down 65%, Is Viking Therapeutics Stock a Buy on the Dip?
Via The Motley Fool
Viking Therapeutics Stock Down Over 20% In 2025: Retail Traders Predict Where It Could End The Year
Via Stocktwits
We Asked Retail Traders About Eli Lilly’s Biggest Post-Q4 Risk — Most Say It’s The Weight-Loss Drug Wars
Via Stocktwits
Market Movers: $ASTS Surges Again, $PBI Gears Up For Earnings!
Via Talk Markets
Topics Stocks / Equities
Viking Therapeutics Plummeted 10% On Its Earnings Report. Here's Why.
Via Investor's Business Daily
Here's How Much $1000 Invested In Viking Therapeutics 5 Years Ago Would Be Worth Today
Via Benzinga
Viking Therapeutics Shares Drop After Q4 EPS Miss Estimates
Via Benzinga
This Weight Loss Stock Could Soar Over 220%, According to Wall Street. Time to Buy?
Via The Motley Fool
Jim Cramer: This Industrial Stock Is 'Absolutely Terrific', First Solar Is 'Very Inexpensive'
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Novo Nordisk Jumps On Experimental Weight-Loss Drug Trial Results
Via Investor's Business Daily
Top 3 Health Care Stocks That Could Blast Off This Quarter
Via Benzinga
Why Viking Therapeutics Stock Popped, but Novo Nordisk and Hims & Hers Health Dropped Today
Via The Motley Fool
We Asked Retail How Viking Therapeutics Can Restore Investor Confidence: Majority Say Pursue Buyout Talks
Via Stocktwits
Why Eli Lilly, Novo Nordisk, and Viking Therapeutics Stocks All Dropped on Tuesday
Via The Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.